These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29846316)

  • 21. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flibanserin and Female Sexual Desire.
    Fantasia HC
    Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flibanserin treatment increases appetitive sexual motivation in the female rat.
    Gelez H; Greggain-Mohr J; Pfaus JG; Allers KA; Giuliano F
    J Sex Med; 2013 May; 10(5):1231-9. PubMed ID: 23421417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of safety for flibanserin.
    Clayton AH; Brown L; Kim NN
    Expert Opin Drug Saf; 2020 Jan; 19(1):1-8. PubMed ID: 31855607
    [No Abstract]   [Full Text] [Related]  

  • 25. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 26. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications.
    Kingsberg SA; McElroy SL; Clayton AH
    Sex Med Rev; 2019 Jul; 7(3):380-392. PubMed ID: 30803922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.
    Johnson-Agbakwu C; Brown L; Yuan J; Kissling R; Greenblatt DJ
    Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flibanserin.
    Vallejos X; Wu C
    J Pharm Pract; 2017 Apr; 30(2):256-260. PubMed ID: 26873507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
    Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
    Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.
    Ferger B; Shimasaki M; Ceci A; Ittrich C; Allers KA; Sommer B
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):573-9. PubMed ID: 20422156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

  • 36. Flibanserin Ineffective for Hypoactive Sexual Desire Disorder in Women.
    Shaughnessy AF
    Am Fam Physician; 2016 Sep; 94(5):384-6. PubMed ID: 27583427
    [No Abstract]   [Full Text] [Related]  

  • 37. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.
    Croft HA
    J Sex Med; 2017 Dec; 14(12):1575-1584. PubMed ID: 29198512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Simon JA; Clayton AH; Parish SJ; Apfel SC; Millheiser L
    J Sex Med; 2020 Jan; 17(1):83-93. PubMed ID: 31735618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for hypoactive sexual desire.
    Pfaus JG
    Cell; 2015 Oct; 163(3):533. PubMed ID: 26496594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.